ArticleThe journal of liquid biopsy2024
Exosomes-based liquid biopsy: An effective approach for drugs and therapeutics resistance screening in cancer.
Article in The journal of liquid biopsy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The mechanism of breast cancer stem cells and tumor microenvironment promoting radioresistance in breast cancer and its intervention strategies.Frontiers in immunology · 2026Pooled it
- Liquid biopsy in cancer drug resistance: real-time monitoring, mechanistic insights, and translational applications.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer drugs and therapeutics resistance are a complicated domain of cancer treatment. Extracellular vesicles (EVs) based cancer investigation reveals several complicated concepts about cancer. EVs are associated with cellular communication. Its bioactive molecular transportation reprograms cellular activity. Exosomes an exciting EVs subpopulation work as masterminds in cancer development and progression. Studies over the past decade have elucidated that exosomes play a vital role in intercellular communication within the tumor microenvironment (TME), influencing multiple events such as hypoxia-induced epithelial-mesenchymal transition (EMT), cancer stemness, angiogenesis, and metastasis. Tumor-derived exosomes (TEXs) associated with drugs and therapeutics resistance development. This article focuses on understanding exosome biology and its implications in cancer drug and therapeutics resistance, exosome-based liquid biopsy application in drug and therapeutic resistance detection, limitations, and future orientation in this domain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.